Peptides / Dulaglutide
Dulaglutide
(Trulicity, LY2963016)T1glp1clinical
Biomarker Effects
No biomarker data available yet.
Dosing & Pharmacokinetics
Typical Dose0.75 mg
Frequencydaily
Routeclinician-directed
Half-Life4.5 days
Safety & Evidence
Dulaglutide is a weekly GLP-1 receptor agonist injection for type 2 diabetes. Marketed as Trulicity. Generally well tolerated with GI side effects.
Sources
Track Dulaglutide precisely in the Vivy app.
Your precision instrument awaits.
Download Vivy